Stephens & Co. Initiates Coverage On TransMedics Gr With Overweight Rating, Announces Price Target of $151
Stephens & Co. Initiates Coverage On TransMedics Gr With Overweight Rating, Announces Price Target of $151
Stephens & Co.開始報導Transmedics Gr的研究,並給予超額評分,目標價格為151美元。
Stephens & Co. analyst George Sellers initiates coverage on TransMedics Gr (NASDAQ:TMDX) with a Overweight rating and announces Price Target of $151.
Stephens&Co.分析師George Sellers開始關注Transmedics公司(納斯達克:TMDX)並給予超額評級,宣佈151美元的目標價格。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。